Jan. 18, 2024

The U.S. Food and Drug Administration (FDA) posted a new information document to assist mammography facilities subject to the Mammography Quality Standards Act (MQSA) final rule. Amended MQSA regulations take effect Sept. 10.

The FDA document highlights the new requirements in the rule, including breast density reporting, other new requirements imposed by the final rule, and additional items MQSA inspectors will look for during annual inspections. It also describes new requirements for: mammography reports; patient lay summaries; communication of results; medical outcomes audits; equipment; personnel records; medical recordkeeping; transfer of records/release of copies; facility responsibility to self-referred patients and accreditation failures.

The document provides links to subscribe to the MQSA listserv to receive email updates when new information about the topic is posted. Questions can be directed to the MQSA Hotline at MQSAhotline@versatechinc.com or 800-838-7715.


Related ACR News

  • Bill Introduced to Expand Access to Lung Cancer Screening

    The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the HRSA, with an emphasis on lung cancer.

    Read more
  • ACR Urges HHS to Promote Annual Lung Cancer Screenings

    In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening.

    Read more
  • FDA Approves Alternative Standard Breast Density Reporting

    The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.

    Read more